Eligibility for duty-free treatment under Nairobi Protocol concerning the ATMOS C 051 Thorax from Germany.
No revocation or modification of this ruling appears in the Customs Bulletin issues read here (Nov 6, 2024 through Nov 18, 2026), where CBP publishes most such actions. That is not confirmation that the ruling is still in effect. Confirm its status with CBP before relying on it (ruling on CBP CROSS).
Ruling text
In your letter dated March 20, 2026, you requested a tariff classification ruling. The item under consideration is the ATMOS C 051 Thorax, a digital, portable thoracic drainage system designed for use with an indwelling chest tube. It enables the continuous evacuation of pleural air and fluid in patients experiencing pneumothorax or persistent pleural air leakage.
The system generates a controlled vacuum near the patient and features an electronic monitoring system that displays both the actual vacuum measured on a patient’s side, and the presence of any air leaks. The Thoracic drainage systems, such as the ATMOS C 051 Thorax, help restore lung expansion by continuously evacuating air and fluid in the pleural space, thereby maintaining the negative intrapleural pressure required for effective ventilation.
This compensatory function is essential for reestablishing the mechanical conditions necessary for proper lung expansion. Pneumothorax or persistent pleural air leakage restricts lung expansion, impairs ventilation and compromises breathing.
Ongoing drainage management and monitoring are especially important in patients with underlying chronic pulmonary diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis, interstitial lung diseases, fibrosing lung diseases, cystic lung diseases, and pulmonary malignancies.
It is important to note that this system is intended for situations where air and fluids in the thorax must be drained, monitored and balanced in a controlled manner and is not suitable for thoracic drainage therapy in which no negative pressure should be applied to the patient. As you noted, the ATMOS C 051 Thorax incorporates design features that distinguish it from conventional thoracic drainage systems intended for short term inpatient use.
It enables safe ambulatory and take-home drainage management for prolonged pleural drainage in patients with impaired respiratory function. Additionally, it utilizes more advanced technology and is offered at much higher product cost compared to conventional drainage systems, which are typically designed for supervised inpatient management and are more economically appropriate for uncomplicated acute or transient drainage situations.
The thoracic drainage systems may be used in both acute and chronic situations; however, prolonged drainage is often required for patients with pre-existing chronic respiratory impairment. These patients benefit significantly from outpatient and home drainage capabilities, as they require longer drainage durations.
According to the operating instructions, the ATMOS C 051 Thorax is intended for use by physicians, healthcare professionals and laypersons who have received mandatory training by a qualified healthcare professional and can be used in a hospital/clinic environment and for home use environment.
In your submission you requested consideration of a secondary classification under 9817.00.96, Harmonized Tariff Schedule of the United Sates (HTSUS), which applies to articles and parts and accessories of articles specifically designed or adapted for the use or benefit of the permanently or chronically physically or mentally handicapped.
The text above is an excerpt. The official ruling, with its letterhead, signature and any attachments, is on CBP CROSS (N359929).